Results 91 to 100 of about 2,545,005 (248)

Zero‐Fluoroscopy Ablation Methods for Atrial Fibrillation: A Systematic Review and Meta‐Analysis

open access: yesPacing and Clinical Electrophysiology, EarlyView.
Central illustration. Schematic comparison of conventional fluoroscopy guided ablation (left) and zero fluoroscopy ablation (right), enabled by electroanatomical mapping and intracardiac echocardiography for catheter navigation without X ray. The study selection process is summarized (133 records identified; 12 studies included, total n = 1998 ...
Marwan Shawki   +5 more
wiley   +1 more source

Amiodarone (cordarone) efficiency in atrial extrasystoles

open access: yesТерапевтический архив, 2004
Aim. To assess antiarrhythmic amiodarone efficacy of suppressing atrial extrasystoles resistant to other antiarrhythmic modalities. Material and methods.
D I Reingardene, A P Azaravichene
doaj  

Cryoballoon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation: Meta‐Analysis of Randomized Trials

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Pulmonary vein isolation (PVI) alone achieves modest arrhythmia freedom in persistent atrial fibrillation (PeAF). Cryoballoon ablation (CBA) offers a single‐shot alternative to radiofrequency ablation (RFA) that streamlines procedural workflow.
Harroop Bola   +8 more
wiley   +1 more source

Preventing Sudden Death And The Use Of Prophylactic Implanted Defibrillators

open access: yesIndian Pacing and Electrophysiology Journal, 2003
Implanted defibrillators have become mainstream therapy for the prevention of sudden cardiac death from ventricular tachyarrhythmias. A decade of studies has confirmed the superiority of ICDs over antiarrhythmic drug therapy in prolonging the life of ...
Indranill Basu Ray
doaj  

Rising Comorbidity Burden in Inpatient Atrial Fibrillation Catheter Ablation: Temporal Trends and In‐Hospital Outcomes

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Despite advancements in catheter ablation (CA) technique and expertise, success rates of atrial fibrillation (AF) ablation have not substantially improved in recent years. Treating patients with advanced age and higher comorbidities may limit success rates while increasing complications.
Eran Leshem   +5 more
wiley   +1 more source

Doxorubicin‐induced Cardiotoxicity in Dogs: A Narrative Review

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Doxorubicin, an anthracycline widely used in both human and veterinary oncology, is highly effective against a variety of malignancies in dogs, including lymphomas, sarcomas and carcinomas. Despite its efficacy, doxorubicin exposure can be associated with cardiotoxicity, which may present acutely or chronically, potentially leading to severe ...
Supita Sunpongsri   +4 more
wiley   +1 more source

Lifestyle modification in atrial fibrillation: Mechanisms, phenotypes and ablation outcomes

open access: yesExperimental Physiology, EarlyView.
Abstract Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia and is associated with significant morbidity, mortality and healthcare utilization. Catheter ablation is increasingly used as a rhythm‐control intervention for patients with symptomatic paroxysmal and persistent AF, yet recurrence rates remain suboptimal.
Konstantinos Grigoriou   +11 more
wiley   +1 more source

New possibilities of antiarrhythmic therapy of atrial fibrillation: A review

open access: yesТерапевтический архив
Atrial fibrillation (AF) is the most common heart rhythm disorder. According to current recommendations, the treatment of AF includes 3 main directions: "A" – the appointment of anticoagulant therapy with an increased risk of thromboembolic complications,
Aida I. Tarzimanova, Alena Iu. Isaeva
doaj   +1 more source

Tratamento de arritmias ventriculares malignas guiado por estudo electrofisiológico.

open access: yesActa Médica Portuguesa, 1998
The purpose of this study was to assess the results of the treatment of malignant ventricular tachyarrhythmias guided by electrophysiologic studies. Thirty patients with ventricular arrhythmias, aged 56.6 +/- 14.1 years, were submitted to EP testing. The
L Brandão   +3 more
doaj   +1 more source

A new approach to an old disease: Ageing, arrhythmogenic substrate and the role of risk‐factor modification in atrial fibrillation

open access: yesExperimental Physiology, EarlyView.
Abstract Atrial fibrillation (AF) prevalence rises sharply with age due to two independent mechanisms. Ageing produces irreversible arrhythmogenic substrate changes through progressive fibrosis, cellular senescence and mitochondrial dysfunction, while modifiable risk factors such as obesity, hypertension, sleep apnoea, diabetes and alcohol use promote ...
Udit Thakur, Jonathan M. Kalman
wiley   +1 more source

Home - About - Disclaimer - Privacy